Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  gusperimus
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-8 of 8 for your search:
Start Over
Phase II Trial of Deoxyspergualin in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 07/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: MSKCC-90152, NCI-T90-0225C, T90-0225
Phase II Study of DSG Followed by a Salvage Regimen of CDDP/VP-16 in Patients with Extensive Small Cell Lung Cancer (Summary Last Modified 07/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-DM-90101, NCI-T90-0226C, T90-0226
Phase II Study of DSG in Patients with Refractory Metastatic Breast Cancer (Summary Last Modified 07/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-90108, NCI-T90-0253C, T90-0253
Phase II Study of Deoxyspergualin in Patients with Recurrent Intermediate- and High-Grade non-Hodgkin's Lymphoma (Summary Last Modified 08/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MSKCC-91053, NCI-T91-0046C, T91-0046
Phase I Chemotherapy with Deoxyspergualin in Patients with Advanced Cancer (Summary Last Modified 08/89)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-8640, NCI-T86-0052W, T86-0052
Phase I Chemotherapy with Continuous Infusion Deoxyspergualin in Patients with Solid Tumors (Summary Last Modified 07/89)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UTHSC-8565011093, NCI-T85-0276W, T85-0276
Phase I Study of DSG Combined with MOAB L6 in Patients with Disseminated Carcinomas (Summary Last Modified 09/92)
Phase: Phase I
Type: Treatment
Status: Completed
Age: over 16
Sponsor: NCI
Protocol IDs: MDA-DM-91009, NCI-T91-0073D, T91-0073
Phase I Pilot Study of Intravenous 131I-CC49 Monoclonal Antibody with Deoxyspergualin Immunomodulation in Patients with Advanced Colorectal Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-93029, NCI-B92-0002, B92-0002
Start Over